Foresite Capital Management VI as of March 31, 2026
Portfolio Holdings for Foresite Capital Management VI
Foresite Capital Management VI holds 17 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 32.7 | $150M | 2.2M | 67.68 | |
| Alumis (ALMS) | 20.3 | $94M | 4.2M | 22.03 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 11.8 | $54M | 1.4M | 39.72 | |
| Corvus Pharmaceuticals (CRVS) | 5.8 | $27M | 1.8M | 14.63 | |
| Denali Therapeutics (DNLI) | 5.0 | $23M | 1.2M | 19.20 | |
| Agios Pharmaceuticals (AGIO) | 3.9 | $18M | 525k | 33.83 | |
| Verastem (VSTM) | 3.6 | $17M | 3.1M | 5.30 | |
| Kymera Therapeutics (KYMR) | 2.6 | $12M | 146k | 83.29 | |
| Minerva Neurosciences (NERV) | 2.6 | $12M | 2.0M | 6.03 | |
| Celldex Therapeutics (CLDX) | 2.2 | $10M | 316k | 31.72 | |
| Ataibeckley (ATAI) | 2.1 | $9.7M | 2.8M | 3.54 | |
| Hinge Health Cl A (HNGE) | 1.8 | $8.5M | 220k | 38.56 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.7 | $7.7M | 212k | 36.32 | |
| OnKure Therapeutics Com Cl A (OKUR) | 1.3 | $6.0M | 1.4M | 4.14 | |
| Jade Biosciences (JBIO) | 1.0 | $4.5M | 320k | 14.05 | |
| GH Research Ord (GHRS) | 1.0 | $4.4M | 316k | 14.06 | |
| Zura Bio Cl A (ZURA) | 0.6 | $2.7M | 450k | 5.95 |
